Watchlist Price Alert

Psyence Biomedical Ltd. (PBM)

NASDAQ: PBM · Real-Time Price · USD

4.65

-0.32 (-6.44%)

At close: Jun 12, 2025, 3:59 PM

4.74

1.94%

Pre-market: Jun 13, 2025, 07:15 AM EDT

Psyence Biomedical Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	n/a	-632.1K	-557.05K	-512.09K	-771.49K	-510.93K	-163.13K	-293.02K	-326.9K	-254.8K	-45.06K
Interest Income	n/a	n/a	n/a	187.84K	485.6K	2.63M	799.27K	115.55K	6.29K	2.42K	n/a
Pretax Income	141.47K	-24.76M	-647.77K	-62.84K	-24.49K	2.25M	766.84K	2.04M	2.95M	8.31M	-45.06K
Net Income	141.47K	-24.76M	-647.77K	-62.84K	-24.49K	2.25M	766.84K	2.04M	2.95M	8.31M	-45.06K
Selling & General & Admin	890.48K	556.97K	557.05K	512.09K	771.49K	510.93K	163.13K	293.02K	326.9K	254.79K	45.06K
Research & Development	265.63K	75.14K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	1.02K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.16M	632.1K	557.05K	512.09K	771.49K	510.93K	163.13K	293.02K	326.9K	254.79K	45.06K
Interest Expense	3.71K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	273.77K	39.22K	1.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.16M	632.1K	557.05K	512.09K	771.49K	510.93K	163.13K	293.02K	326.9K	254.79K	45.06K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	276.73K	13.39M	7.69M	8.04M	11.43M	32.67M	28.54M	28.54M	28.54M	32.67M	32.75M
Shares Outstanding (Diluted)	276.73K	13.39M	7.69M	8.04M	11.43M	32.67M	28.54M	28.54M	28.54M	32.67M	32.75M
EPS (Basic)	38.35	-1.85	-0.08	-0.01	-0.00	n/a	0.03	0.07	0.10	0.25	-0.00
EPS (Diluted)	38.34	-1.85	-0.08	-0.01	-0.00	n/a	0.03	0.07	0.10	0.25	-0.00
EBITDA	146.2K	-632.1K	-557.05K	-512.09K	-771.49K	-510.93K	-163.13K	-293.02K	-326.9K	-254.8K	-45.06K
EBIT	145.19K	-632.22K	-173.85K	-62.84K	-24.49K	-1.3M	-244K	2.04M	2.95M	8.31M	-45.06K
Depreciation & Amortization	1.02K	120.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a